Identification of nonfunctional SPATA20 causing acephalic spermatozoa syndrome in humans

Clin Genet. 2023 Mar;103(3):310-319. doi: 10.1111/cge.14268. Epub 2022 Nov 30.

Abstract

Acephalic spermatozoa syndrome (ASS) is a rare and severe type of teratozoospermia characterized by the predominance of headless spermatozoa in the ejaculate. However, knowledge about the causative genes associated with ASS in humans is limited. Loss-of-function of SPATA20 has been suggested to result in the separation of the sperm head and flagellum in mice, whereas there have been no cases reporting SPATA20 variants leading to human male infertility. In this study, a nonsense mutation in SPATA20 (c.619C > T, p.Arg207*) was first identified in an ASS patient. Moreover, this variant contributed to the degradation of SPATA20 and was associated with decreased expression of SPATA6, which plays a vital role in the assembly of the sperm head-tail conjunction in humans. In addition, the infertility caused by loss-of-function mutation of SPATA20 might not be rescued by intracytoplasmic sperm injection (ICSI). Collectively, our findings suggested that SPATA20 might be required for sperm head-tail conjunction formation in humans, the nonfunction of which may lead to male infertility related to ASS. The discovery of the loss-of-function mutation in SPATA20 enriches the gene variant spectrum of human ASS, further contributing to improved diagnosis, genetic counseling and prognosis for male infertility.

Keywords: SPATA20; SPATA6; acephalic spermatozoa syndrome; male infertility.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cytoskeletal Proteins / genetics
  • Humans
  • Infertility, Male* / genetics
  • Male
  • Mutation
  • Semen*
  • Sperm Head / metabolism
  • Spermatozoa / metabolism
  • Teratozoospermia* / genetics

Substances

  • Cytoskeletal Proteins
  • SPATA6 protein, human
  • SPATA20 protein, human